Fundz

hema.to raised €3.6M in a funding round led by LUMO Labs to refine product-market-fit for blood cancer diagnostics and expand into broader immune disorders.

PRIVATEMar 06, 2025

Amount Raised

€3.6 Million

Round Type

Seed

MunichBiotechnologyHealth Care

Investors

Bayern KapitalLUMO Labs

Description

hema.to, a Munich-based digital medtech company, raised €3.6M in funding. The funds will be used for product-market-fit refinement, European certification, clinical studies, and commercial deployment.

Quick answer

hema.to raised €3.6 Million in a Seed round, dated March 6, 2025. Investors: Bayern Kapital and LUMO Labs. hema.to is based in Munich, Bavaria, Germany.

How much did hema.to raise?
hema.to raised €3.6 Million in a Seed round on March 6, 2025.
Who invested in hema.to?
Bayern Kapital and LUMO Labs are named as investors in this round.
What does hema.to do?
hema.to provides fully automated, AI-powered diagnosis recommendations for blood cancer from flow cytometry data.
Where is hema.to based and how big is it?
hema.to is based in Munich, Bavaria, Germany. Fundz records about 29 employees.
Who are the decision-makers at hema.to?
Fundz holds 1 contact at hema.to. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as hema.to that raised within 45 days of this round, from Fundz verified event records.

  • AMT Medical raised $25M (Series B) on April 17, 2025.
  • RISA Labs raised $3.5M (Seed) on April 17, 2025.
  • Lexington Medical raised an undisclosed amount (Corporate Round) on April 17, 2025.
  • Pathos AI raised $283M on April 17, 2025.
  • Skin Analytics raised $20M (Series B) on April 16, 2025.
  • Medcura raised $29M on April 16, 2025.

Who to call at hema.to, and when

A new round usually means hema.to is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day hema.to raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at hema.to, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at hema.to. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

hema.to

Location

Munich, Bavaria, Germany

About

hema.to provides fully automated, AI-powered diagnosis recommendations for blood cancer from flow cytometry data. Diagnosticians using hema.to not only showed a higher speed but could also achieve an increase in quality.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment hema.to raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for hema.to's next move

See what Strategic adds

hema.to raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.